A Systematic Review: Quercetin-Secondary Metabolite of the Flavonol Class, with Multiple Health Benefits and Low Bioavailability.
Level 5 - mechanism / opinion, no new human data
Broad review synthesizing chemical, biosynthetic, preclinical mechanistic, and delivery-system literature rather than randomized clinical trials
PubMed 39596162 · doi:10.3390/ijms252212091
What was done
The authors conducted a review to evaluate literature on the flavonol quercetin, focusing on its chemical structure, plant biosynthesis, natural sources, biological activities (antioxidant, anti-inflammatory, antibacterial, and anticancer properties), and formulation delivery systems designed to improve its bioavailability.
What was found
The abstract reports no quantitative data or effect sizes. It qualitatively describes quercetin as having multiple biological activities that are limited in therapeutic application by low bioavailability, which newer delivery systems aim to improve.
Why it matters
Quercetin is a commonly researched dietary supplement and drug candidate. Summarizing its molecular mechanisms alongside novel delivery technologies helps identify how formulation science might address its low systemic absorption.
Limits
The abstract does not report search dates, databases, inclusion criteria, or the number and design of included studies. The findings primarily synthesize bench, preclinical, and mechanistic literature without human trial outcome data.
Cited by
- contradicts Quercetin is classified as a flavan-3-ol.